These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12841155)

  • 1. Selecting medical devices and materials for development in Korea: the analytic hierarchy process approach.
    Cho KT; Kim SM
    Int J Health Plann Manage; 2003; 18(2):161-74. PubMed ID: 12841155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health technology assessment for medical devices in Europe. What must be considered.
    Siebert M; Clauss LC; Carlisle M; Casteels B; de Jong P; Kreuzer M; Sanghera S; Stokoe G; Trueman P; Lang AW;
    Int J Technol Assess Health Care; 2002; 18(3):733-40. PubMed ID: 12391964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid medical advances challenge the tooling industry.
    Conley B
    Med Device Technol; 2008; 19(3):32-3. PubMed ID: 18557407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health technology assessment from a Canadian device industry perspective.
    Ferrusi IL; Ames D; Lim ME; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):353-9. PubMed ID: 19394576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating health economics modeling in the product development cycle of medical devices: a Bayesian approach.
    Vallejo-Torres L; Steuten LM; Buxton MJ; Girling AJ; Lilford RJ; Young T
    Int J Technol Assess Health Care; 2008; 24(4):459-64. PubMed ID: 18828941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. And then there were three. With consolidation leaving three major players in each sector of the medical device industry, what happens to competition?
    Becker C
    Mod Healthc; 2005 May; 35(20):6-7, 12, 1. PubMed ID: 15926359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The medical device industry in Italy.
    Med Device Technol; 2006 Sep; 17(7):46-7. PubMed ID: 17039959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes research affecting devices.
    Wagner M
    Mod Healthc; 1991 Feb; 21(6):54. PubMed ID: 10109044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health Technology Assessment: managing the introduction and use of medical devices in clinical practice in Italy.
    Migliore A; Ratti M; Cerbo M; Jefferson T
    Expert Rev Med Devices; 2009 May; 6(3):251-7. PubMed ID: 19419283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Old ways of planning, thinking won't work in today's volatile health care industry.
    Egger E
    Health Care Strateg Manage; 1999 Sep; 17(9):18-9. PubMed ID: 10621257
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical decision support using the Analytic Hierarchy Process.
    Sloane EB; Liberatore MJ; Nydick RL
    J Healthc Inf Manag; 2002; 16(4):38-43. PubMed ID: 12365298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budgetary decision making during times of scarcity.
    Jarris PE; Leider JP; Resnick B; Sellers K; Young JL
    J Public Health Manag Pract; 2012; 18(4):390-2. PubMed ID: 22635196
    [No Abstract]   [Full Text] [Related]  

  • 14. Experiences of new product development in the medical device industry.
    Dixon D; Brown A; Meenan BJ; Eatock J
    Med Device Technol; 2006 Apr; 17(3):20-2. PubMed ID: 16736659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early technology assessment of new medical devices.
    Pietzsch JB; Paté-Cornell ME
    Int J Technol Assess Health Care; 2008; 24(1):36-44. PubMed ID: 18218167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of medical devices: how to conduct comparative technology evaluations of product performance.
    Burns LR; Bradlow ET; Lee JA; Antonacci AC
    Int J Technol Assess Health Care; 2007; 23(4):455-63. PubMed ID: 17937834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boston Scientific scores. Dollar 27 billion dealfor Guidant moves it into new sector.
    Becker C
    Mod Healthc; 2006 Jan; 36(5):17. PubMed ID: 16479778
    [No Abstract]   [Full Text] [Related]  

  • 18. Year 2006 update of the Israel National List of Health Services.
    Tamir O; Rabinovich M; Shani M
    Isr Med Assoc J; 2006 Sep; 8(9):595-600. PubMed ID: 17058406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blizzard deals. In a sure sign of a robust industry, companies recently have gotten in the spirit to merge and acquire.
    Galloro V
    Mod Healthc; 2004 Dec; 34(50):6-7, 1. PubMed ID: 15631144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The comparative evaluation of expanded national immunization policies in Korea using an analytic hierarchy process.
    Shin T; Kim CB; Ahn YH; Kim HY; Cha BH; Uh Y; Lee JH; Hyun SJ; Lee DH; Go UY
    Vaccine; 2009 Jan; 27(5):792-802. PubMed ID: 19014990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.